Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
365-01-003 ISMRM Abstract

Layer-Specific Myocardial Strain by CMR-FT Differentiates Hypertrophic Cardiomyopathy from Hypertensive Heart Disease

Primary: Cardiovascular - Myocardium
Secondary: Analysis Methods
365-01-003 · Cardiomyopathies · Monday, 11 May, 8:20 AM–9:15 AM · Digital Posters Row F
Keywords: Hypertrophic cardiomyopathy Strain Feature tracking Hypertensive heart disease Layer fMRI
Accepted
Yunxiao Yan 1, Ningning Song1, Tingting Liu2, Min Wu1, MENGZHU WANG3, Li Kaixin4, Weibin Dai1, Jiang Wu5, Yanfeng Meng1
1Department of Radiology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, China
2Department of Radiology, Shanxi Bethune Hospital, Taiyuan, China
3MR Research Collaboration, Siemens Healthineers, Beijing China, China
4MR Research Collaboration, Siemens Healthineers Ltd., Beijing, China
5Magnetic Resonance Room, Shanxi Cardiovascular Hospital, Taiyuan, China
Presenting Author: Yunxiao Yan

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. N Engl J Med. 2018;379(20):1977.
2. Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-2779.
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertens Dallas Tex 1979. 2003;42(6):1206-1252.
4. Jc R, Am A, Ag D, et al. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart Br Card Soc. 2016;102(20).
5. Giusca S, Steen H, Montenbruck M, et al. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2021;23(1):92.
6. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761-2796.
7. Kuruvilla S, Janardhanan R, Antkowiak P, et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging. 2015;8(2):172-180.
8. Kato TS, Noda A, Izawa H, et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation. 2004;110(25):3808-3814.
9. Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular Magnetic Resonance Myocardial Feature Tracking: Concepts and Clinical Applications. Circ Cardiovasc Imaging. 2016;9(4):e004077.
10. Shi J, Pan C, Kong D, Cheng L, Shu X. Left Ventricular Longitudinal and Circumferential Layer-Specific Myocardial Strains and Their Determinants in Healthy Subjects. Echocardiogr Mt Kisco N. 2016;33(4):510-518.
11. Tanacli R, Hashemi D, Lapinskas T, et al. Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure. Sci Rep. 2019;9(1):16478.
12. Neisius U, Myerson L, Fahmy AS, et al. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy. PloS One. 2019;14(8):e0221061.
13. Liu S, Li Y, Zhao Y, et al. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease. Front Cardiovasc Med. 2022;9:865615.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/365-01-003